Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 876 - 900 of 917 in total
Investigational
Matched Salts name: … Pralmorelin hydrochloride
ZM-39923 is a small molecule that inhibits Janus kinase and human tissue transglutaminase (TGM2).
Investigational
Matched Salts name: … ZM-39923 hydrochloride
A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence.
Experimental
Illicit
Matched Salts name: … Methadyl acetate hydrochloride
SB-224289 is a small molecule with a high affinity for human 5-HT1B receptors.
Investigational
Matched Salts name: … SB 224289 hydrochloride
ASP4058 has been used in trials studying Food Effect of ASP4058 and Pharmacokinetics of ASP4058.
Investigational
Matched Salts name: … Asp 4058 Hydrochloride
RS-39604 is a selective 5-HT4 receptor antagonist.
Investigational
Matched Salts name: … RS-39604 hydrochloride
Rezatomidine has been used in trials studying the treatment of Fibromyalgia, Cystitis, Interstitial, Irritable Bowel Syndrome, and Diabetic Neuropathy, Painful.
Investigational
Matched Salts name: … Agn 203818 Hydrochloride
BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.
Investigational
Matched Salts name: … BMS-863233 hydrochloride
PHA-767491 is a Cdc7/CDK9 inhibitor.
Investigational
Matched Salts name: … PHA-767491 hydrochloride
An essential branched-chain amino acid important for hemoglobin formation.
Investigational
Nutraceutical
Matched Salts name: … L-Leucine hydrochloride
Specific inhibitor of phosphatidylinositol 3-kinase.
Experimental
Matched Salts name: … LY-294002 hydrochloride
SB-269970 is an experimental drug developed by GlaxoSmithKline. In the studies performed with this agent, it has been suggested that SB-269970 acts either as a selective antagonist or inverse agonist of the serotonin receptor 7 (5-HT7).[A31816,A31817]
Investigational
Matched Salts name: … SB-269970 hydrochloride
PF-03758309 has been used in trials studying the treatment of Advanced Solid Tumors.
Investigational
Matched Salts name: … Pf 03758309 Hydrochloride
Investigational
Matched Salts name: … Fostroxacitabine bralpamide hydrochloride
Investigational
Bradanicline, a novel small molecule that modulates the activity of the neuronal nicotinic receptor (NNR) subtype known as alpha7(α7). Bradanicline belongs to a new class of drugs for the treatment of central nervous system diseases and disorders.
Investigational
Matched Salts name: … Bradanicline hydrochloride
Ruboxistaurin has been investigated for the basic science of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus.
Investigational
Matched Salts name: … Ruboxistaurin hydrochloride
Sapanisertib has been used in trials studying the treatment of HCC, Solid Tumor, Gliosarcoma, Liver Cancer, and Glioblastoma, among others.
Investigational
Matched Salts name: … Sapanisertib Hydrochloride
Gepotidacin has been used in trials studying the treatment of Gonorrhea, Infections, Bacterial, and Infections, Respiratory Tract.
Investigational
Matched Salts name: … Gepotidacin Hydrochloride
Experimental
Illicit
Matched Salts name: … 2,5-dimethoxyamphetamine hydrochloride
Roxatidine acetate is a specific and competitive H2 receptor antagonist. It is currently approved in South Africa under the tradename Roxit.
Experimental
Matched Salts name: … Roxatidine acetate hydrochloride
Navitoclax has been used in trials studying the treatment and basic science of Solid Tumors, Non-Hodgkin's Lymphoma, EGFR Activating Mutation, Chronic Lymphoid Leukemia, and Hematological Malignancies, among others. Navitoclax is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins. It is a substance being studied in the treatment of...
Investigational
A thiol-containing non-essential amino acid that is oxidized to form CYSTINE.
Experimental
Matched Salts name: … D-Cysteine hydrochloride monohydrate …
Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.
Investigational
Matched Salts name: … Ozagrel Hydrochloride
Ceftiofur is a third generation cephalosporin antibiotic, first described in 1987, and now used in veterinary medicine. It is marketed by pharmaceutical company Zoetis as Excenel, and is the active ingredient in that company's Specramast LC (lactating cow formula) product. It is resistant to hydrolysis by beta-lactamase, and has activity...
Vet approved
Matched Salts name: … Ceftiofur hydrochloride
Displaying drugs 876 - 900 of 917 in total